seed
Stage
2
Investors
About
ReNewVax is a next-generation bacterial vaccine company developing a universal vaccine targeting all variants of S. pneumoniae to tackle antimicrobial resistance and prevent serious infections.
Explore ReNewVax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.